| Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3 T A Doskaliyev, F Yamasaki, M Ohtaki, Y Kajiwara, Y Takeshima, ... European journal of radiology 81 (2), 339-344, 2012 | 148 | 2012 |
| Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas VJ Amatya, Y Takeshima, K Sugiyama, K Kurisu, T Nishisaka, T Fukuhara, ... Human pathology 32 (9), 970-975, 2001 | 143 | 2001 |
| Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma K Kushitani, Y Takeshima, VJ Amatya, O Furonaka, A Sakatani, K Inai Pathology international 57 (4), 190-199, 2007 | 130 | 2007 |
| TP53 promoter methylation in human gliomas VJ Amatya, U Naumann, M Weller, H Ohgaki Acta neuropathologica 110, 178-184, 2005 | 124 | 2005 |
| Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas OM Mahmoud, A Tominaga, VJ Amatya, M Ohtaki, K Sugiyama, ... European journal of radiology 80 (2), 412-417, 2011 | 97 | 2011 |
| Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma Y Takeshima, VJ Amatya, K Kushitani, M Kaneko, K Inai Histopathology 54 (6), 667-676, 2009 | 83 | 2009 |
| Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry K Kushitani, Y Takeshima, VJ Amatya, O Furonaka, A Sakatani, K Inai Pathology international 58 (2), 75-83, 2008 | 83 | 2008 |
| CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma K Aoe, VJ Amatya, N Fujimoto, K Ohnuma, O Hosono, A Hiraki, M Fujii, ... Clinical Cancer Research 18 (5), 1447-1456, 2012 | 70 | 2012 |
| Methylation of p14ARF gene in meningiomas and its correlation to the p53 expression and mutation VJ Amatya, Y Takeshima, K Inai Modern Pathology 17 (6), 705-710, 2004 | 69 | 2004 |
| A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases Y Takeshima, VJ Amatya, K Kushitani, K Inai American journal of clinical pathology 130 (5), 771-779, 2008 | 66 | 2008 |
| Expression of vascular endothelial growth factor‐C and its receptor in invasive micropapillary carcinoma of the breast Y Li, M Kaneko, VJ Amatya, Y Takeshima, K Arihiro, K Inai Pathology international 56 (5), 256-261, 2006 | 62 | 2006 |
| Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma H Kohno, VJ Amatya, Y Takeshima, K Kushitani, N Hattori, N Kohno, ... Oncology reports 24 (2), 423-431, 2010 | 60 | 2010 |
| Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer S Ohara, N Oue, A Matsubara, K Mita, Y Hasegawa, T Hayashi, T Usui, ... Cancer science 99 (8), 1570-1577, 2008 | 58 | 2008 |
| Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging F Yamasaki, K Sugiyama, M Ohtaki, Y Takeshima, N Abe, Y Akiyama, ... European journal of radiology 73 (3), 532-537, 2010 | 57 | 2010 |
| miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma R Suzuki, VJ Amatya, K Kushitani, Y Kai, T Kambara, Y Takeshima Frontiers in oncology 8, 446, 2018 | 53 | 2018 |
| Meningioangiomatosis occurring in a young male without neurofibromatosis: with special reference to its histogenesis and loss of heterozygosity in the NF2 gene region Y Takeshima, VJ Amatya, F Nakayori, T Nakano, K Sugiyama, K Inai The American journal of surgical pathology 26 (1), 125-129, 2002 | 51 | 2002 |
| Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma F Yamasaki, T Takayasu, R Nosaka, VJ Amatya, A Doskaliyev, Y Akiyama, ... Journal of neurosurgery 122 (6), 1370-1379, 2015 | 50 | 2015 |
| Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement T Hirose, S Nobusawa, K Sugiyama, VJ Amatya, N Fujimoto, A Sasaki, ... Brain Pathology 28 (5), 684-694, 2018 | 49 | 2018 |
| Sellar atypical teratoid/rhabdoid tumor (AT/RT): a clinicopathologically and genetically distinct variant of AT/RT S Nakata, S Nobusawa, T Hirose, S Ito, N Inoshita, S Ichi, VJ Amatya, ... The American journal of surgical pathology 41 (7), 932-940, 2017 | 46 | 2017 |
| Accuracy of pathological diagnosis of mesothelioma cases in Japan: clinicopathological analysis of 382 cases Y Takeshima, K Inai, VJ Amatya, K Gemba, K Aoe, N Fujimoto, K Kato, ... Lung cancer 66 (2), 191-197, 2009 | 45 | 2009 |
Yukio TakeshimaHiroshima UniversityVerified email at hiroshima-u.ac.jp
